Clinical evaluation of Perumbadu Nivarani for vaadha perumbadu(DUB)
Phase 2
Completed
- Conditions
- Health Condition 1: null- Patients with a symptom of Excessive bleeding during menstrual phase
- Registration Number
- CTRI/2017/07/008966
- Lead Sponsor
- self
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
1.Patients having symptoms of increased reddish black menstrual bleeding
2.Blood clots seen in menstrual bleeding
3.Distended abdomen
4.Headache and Low back ache
5.Patients willing to undergo routine blood investigations
6.Patient willing to undergo USG pelvis
Exclusion Criteria
1. Pregnancy and lactation
2. Endometriosis
3. Adenomyosis
4. Uterine cancer
5. Any other serious illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is assessed by the reduction of menstrual bleeding with Pbac scoreTimepoint: 1-5 days
- Secondary Outcome Measures
Name Time Method Reduction of other symptoms like dropsy,depression, distended abdomen,tirednessTimepoint: 1-3 months